Facilitated By

San Antonio Medical Foundation

News

  • Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of ...

    ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology ... Initial Phase 1 data was presented at the San Antonio Breast Cancer Symposium in December ...

  • Scilex Holding Company filed SEC Form 8-K: Regulation FD Disclosure - Quantisnow

    Identification No.) 960 San Antonio Road , Palo Alto , California , 94303. (Address of principal executive offices, including zip code).

  • At this year's ObesityWeek, GLP-1s aren't the only talk of the town - Endpoints News

    SAN ANTONIO — As the GLP-1 class has taken over in recent years, a once-fringe conference has come into the spotlight for the biopharma industry.

  • Demand for San Antonio flights hits record pace - The Business Journals

    Demand for San Antonio flights hits record pace. Heightened traffic has underscored the need to advance the city's $2.5 billion airport expansion plan ...

  • BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast ...

    ... San Antonio Breast Cancer Symposium (SABSC), from December 10-13, 2024, San Antonio, Texas. BioMark' Chief Scientific Officer, Jean-François ...